Sivik Global Healthcare’s IQVIA IQV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-17,500
Closed -$3.44M 43
2023
Q3
$3.44M Sell
17,500
-10,000
-36% -$2.17M 1.74% 30
2023
Q2
$6.18M Buy
27,500
+7,500
+38% +$1.51M 1.45% 22
2023
Q1
$3.98M Buy
20,000
+5,000
+33% +$1.07M 1.71% 30
2022
Q4
$3.07M Buy
15,000
+5,000
+50% +$1.01M 1.45% 30
2022
Q3
$1.81M Sell
10,000
-7,500
-43% -$1.64M 1.01% 35
2022
Q2
$3.8M Sell
17,500
-2,500
-13% -$543K 2.16% 23
2022
Q1
$4.62M Buy
20,000
+5,000
+33% +$1.18M 1.91% 28
2021
Q4
$4.23M Sell
15,000
-20,000
-57% -$5.19M 1.81% 27
2021
Q3
$8.38M Hold
35,000
2% 16
2021
Q2
$8.48M Sell
35,000
-10,000
-22% -$2.31M 1.66% 15
2021
Q1
$8.69M Hold
45,000
3.17% 6
2020
Q4
$8.06M Buy
45,000
+15,000
+50% +$2.53M 3.29% 10
2020
Q3
$4.73M Buy
+30,000
New +$4.7M 2.03% 28
2020
Q1
Sell
-35,000
Closed -$5.41M 51
2019
Q4
$5.41M Buy
35,000
+5,000
+17% +$730K 2.01% 26
2019
Q3
$4.48M Buy
30,000
+15,000
+100% +$2.33M 2.26% 24
2019
Q2
$2.41M Buy
+15,000
New +$2.1M 0.58% 50
2016
Q1
Sell
-40,000
Closed -$2.75M 62
2015
Q4
$2.75M Buy
+40,000
New +$2.73M 1.3% 35

Other funds holding IQV

Sivik Global Healthcare's IQV Position: Q4 2023 in Review

Sivik Global Healthcare sold out of IQVIA (IQV) in Q4 2023, closing a stake of 17,500 shares — an estimated $3.44M sold.

Sivik Global Healthcare first reported a position in IQV in Q4 2015 and held it in 17 quarters. The position peaked at $8.69M in Q1 2021. 956 funds tracked by Wall St. Rank hold IQV as of Q4 2023.

  • Sivik Global Healthcare reported no remaining IQVIA position as of Q4 2023 after selling out during the quarter.
  • Sivik Global Healthcare sold 17,500 IQVIA shares in Q4 2023, an estimated $3.44M.
  • Sivik Global Healthcare first reported a position in IQVIA in Q4 2015 and held it in 17 quarters.
  • Sivik Global Healthcare's IQVIA position peaked at $8.69M in Q1 2021.
  • 956 funds tracked by Wall St. Rank held IQVIA as of Q4 2023.

Based on Sivik Global Healthcare's 13F filing for Q4 2023, filed 5 Feb 2024.